Sulforaphane attenuates EGFR signaling in NSCLC cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1423-0127

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Sulforaphane attenuates EGFR signaling in NSCLC cells ; volume:22 ; number:1 ; day:3 ; month:6 ; year:2015 ; pages:1-9 ; date:12.2015
Journal of biomedical science ; 22, Heft 1 (3.6.2015), 1-9, 12.2015

Creator: Chen, Chi-Yuan
Yu, Zhu-Yun
Chuang, Yen-Shu
Huang, Rui-Mei
Wang, Tzu-Chien V.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12929-015-0139-x

URN: urn:nbn:de:101:1-2021081407282322083858

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Chen, Chi-Yuan
Yu, Zhu-Yun
Chuang, Yen-Shu
Huang, Rui-Mei
Wang, Tzu-Chien V.
SpringerLink (Online service)

Other Objects (12)

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Hochschulschrift

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Hochschulschrift

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Hochschulschrift

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Hochschulschrift

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Hochschulschrift

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Hochschulschrift

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Sulforaphane attenuates EGFR signaling in NSCLC cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway

Interactions of EGFR/IGF-1 signaling in NSCLC : a systems biology approach

Interactions of EGFR/IGF-1R Signaling in NSCLC - A Systems Biology Approach

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

EGFR exon 20 insertion mutations in NSCLC

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway

Related objects

Reset password